Evidence map›Paper›PMID 26694089›Full record

ArticleJournal of clinical hypertension (Greenwich, Conn.)2016

The Role of Plasma Triglyceride/High-Density Lipoprotein Cholesterol Ratio to Predict New Cardiovascular Events in Essential Hypertensive Patients.

Osman Turak, Barış Afşar, Fırat Ozcan, Fatih Öksüz, Mehmet Ali Mendi, Çagrı Yayla, Adrian Covic, Nathan Bertelsen, Mehmet Kanbay

Open access · bronzeAbstract read
In one paragraph

Article in Journal of clinical hypertension (Greenwich, Conn.), 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 73 citations in OpenAlex.

  1. Article
  2. Article
  3. Observational
  4. Article
  5. Hemorrhagic stroke and atherogenic markers - is there any relation?Journal of family medicine and primary care · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 2 countries.

Osman TurakDepartment of Cardiology, TürkiyeYüksekIhtisas Education and Research Hospital Ankara, Ankara, Turkey.
Barış AfşarDepartment of Nephrology, Konya Numune Hospital, Konya, Turkey.
Fırat OzcanDepartment of Cardiology, TürkiyeYüksekIhtisas Education and Research Hospital Ankara, Ankara, Turkey.
Fatih ÖksüzDepartment of Cardiology, TürkiyeYüksekIhtisas Education and Research Hospital Ankara, Ankara, Turkey.
Mehmet Ali MendiDepartment of Cardiology, TürkiyeYüksekIhtisas Education and Research Hospital Ankara, Ankara, Turkey.
Çagrı YaylaDepartment of Cardiology, TürkiyeYüksekIhtisas Education and Research Hospital Ankara, Ankara, Turkey.
Adrian CovicNephrology Clinic, Dialysis and Renal Transplant Center, C.I. Parhon University Hospital, and Grigore T. Popa University of Medicine, Iasi, Romania.
Nathan BertelsenDivision of Nephrology, Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
Mehmet KanbayDivision of Nephrology, Department of Medicine, Koc University School of Medicine, Istanbul, Turkey.
Türkiye Yüksek İhtisas Hastanesi · TRKoç University · TRGrigore T. Popa University of Medicine and Pharmacy · ROKonya Numune Hastanesi · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Triglyceride (TG) to high-density lipoprotein cholesterol (HDL-C) ratio (TG/HDL-C) has been suggested as a simple method to identify unfavorable cardiovascular outcomes in the general population. The effect of the TG/HDL-C ratio on essential hypertensive patients is unclear. About 900 consecutive essential hypertensive patients (mean age 52.9±12.6 years, 54.2% male) who visited our outpatient hypertension clinic were analyzed. Participants were divided into quartiles based on baseline TG/HDL-C ratio and medical records were obtained periodically for the occurrence of fatal events and composite major adverse cardiovascular events (MACEs) including transient ischemic attack, stroke, aortic dissection, acute coronary syndrome, and death. Participants were followed for a median of 40 months (interquartile range, 35-44 months). Overall, a higher quartile of TG/HDL-C ratio at baseline was significantly linked with higher incidence of fatal and nonfatal cardiovascular events. Using multivariate Cox regression analysis, plasma TG/HDL-C ratio was independently associated with increased risk of fatal events (hazard ratio [HR], 1.25; 95% confidence interval [CI], 1.13-1.37; P≤.001] and MACEs (HR, 1.13; 95% CI, 1.06-1.21; P≤.001). Increased plasma TG/HDL-C ratio was associated with more fatal events and MACEs in essential hypertensive patients.

Indexed as

AdultAgedCardiovascular DiseasesCholesterol, HDLEssential HypertensionFemaleFollow-Up StudiesHumansHypertensionMaleMiddle AgedSensitivity and SpecificityTriglyceridesCholesterol, HDLTriglycerides

Identifiers

PMID26694089
PMCPMC8031528
OpenAlexW2237313684

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.